homocysteine has been researched along with ciprofibrate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desager, JP; Devuyst, O; Goffin, E; Jamar, F | 1 |
Doolman, R; Gavendo, S; Harats, D; Marko, D; Sela, BA; Shaish, A; Yodfat, O | 1 |
Aru, GM; Mujumdar, VS; Tummalapalli, CM; Tyagi, SC | 1 |
Hunt, MJ; Tyagi, SC | 1 |
Hunt, MJ; Sood, HS; Tyagi, SC | 1 |
1 trial(s) available for homocysteine and ciprofibrate
Article | Year |
---|---|
Homocysteine elevation with fibrates: is it a class effect?
Topics: Adult; Bezafibrate; Clofibric Acid; Dietary Fats; Female; Fibric Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 2001 |
4 other study(ies) available for homocysteine and ciprofibrate
Article | Year |
---|---|
Implication of fibrate therapy for homocysteine.
Topics: Clofibric Acid; Fenofibrate; Fibric Acids; Glomerular Filtration Rate; Homocysteine; Humans; Hypolipidemic Agents; Kidney Transplantation; Renal Plasma Flow, Effective | 1999 |
Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.
Topics: Antineoplastic Agents; Aorta; Cell Culture Techniques; Clofibric Acid; Collagen; Culture Media, Serum-Free; Disintegrins; Endothelium, Vascular; Fibric Acids; Homocysteine; Humans; Metalloendopeptidases; Muscle, Smooth; Peroxisome Proliferators; Platelet Aggregation Inhibitors; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation.
Topics: Animals; Binding, Competitive; Cells, Cultured; Clofibric Acid; Dose-Response Relationship, Drug; Endocardium; Endothelium, Vascular; Fibric Acids; Homocysteine; Intercellular Adhesion Molecule-1; Ligands; Matrix Metalloproteinases; Mice; Myocardium; Prostaglandin D2; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.
Topics: Animals; Aorta; Blood Pressure; Clofibric Acid; Cystathionine beta-Synthase; Endothelium, Vascular; Enzyme Activation; Fibric Acids; Genotype; Homocysteine; Hyperhomocysteinemia; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Peroxisome Proliferators; Phenotype; Proteinuria; Tyrosine | 2003 |